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A qualitative study of anabolic steroid use amongst gym users 
in the United Kingdom: Motives, beliefs and experiences
Abstract
The illicit use of anabolic steroids amongst the gym population continues to rise in the 
United Kingdom presenting serious challenges to public health. This study used qualitative 
interviews to explore the experiences of 24 users of anabolic steroids and investigate their 
motives and experiences. Body satisfaction was a motivating factor in the use of anabolic 
steroids. Anabolic steroid users’ drug use and associated behaviour were influenced by 
numerous sources of information, in particular, first-hand accounts of their peers, along 
with personal opinion and anecdotes on the Internet. As a result of this knowledge, users 
expressed their belief that these drugs can be used relatively safely. The prevailing 
viewpoint, that the harms associated with anabolic steroids can be managed and that this 
behaviour is part of a healthy lifestyle, contributes to the potential health risks.
Keywords
Anabolic steroids, gym population, motivations for use. 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A qualitative study of anabolic steroid use amongst gym users 
in the United Kingdom: Motives, beliefs and experiences
Introduction
The use of anabolic steroids and, more broadly, prohibited doping substances in elite sport 
has been well-known, and thoroughly debated, for decades. While doping techniques and 
specific substance use in competitive athletes varies tremendously (for example, 
depending on type of sport), the overarching aim of this form of drug use is to improve 
performance and to win. Yet most people who use anabolic steroids do not compete in 
organised sport (Baker et al., 2006; Pope et al., in press) and most studies into anabolic 
steroid usage indicate that the main reasons to use these drugs are to enhance the 
performance of muscle, for example by increasing strength, or improving the appearance 
of the body (Evans-Brown et al., 2012).
The use of anabolic steroids amongst gym users has been reported in countries in 
Europe, Australasia, and North America (Sagoe et al., in press), and, more recently, in 
countries such as Brazil (Santos et al., 2011), the United Arab Emirates (Al-Falasi et al., 
2008), and Iran (Allahverdipour et al., 2012). The Crime Survey for England and Wales 
found that 0.2% of those aged 16-59, estimated at 59,000, had taken anabolic steroids in 
the past year (2012/2013) (Home Office, 2013).  Data collected from needle and syringe 1
programmes in Merseyside and Cheshire, North West England, shows a significant 
increase in the number of new steroid injecting clients attending such harm reduction 
services from the 1990s onwards (ACMD, 2010). These data, along with arrests of illicit 
retailers, seizures of illicit market products, media reports, monitoring of discussion forums 
on the Internet, and case reports/series of adverse events, indicate that the use of 
anabolic steroids and other drugs for the purpose of human enhancement is steadily 
growing (Evans-Brown et al., 2012).
Anabolic steroid usage in the gym population presents a challenge to public health, in 
relation to adverse effects (both acute and chronic) amongst users (Pope et al., in press) 
as well as potential exposure to blood borne viruses from the sharing of contaminated 
 Of note is that concerns have been raised regarding the accuracy of these estimates (ACMD, 2010; Evans-1
Brown et al., 2012).
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needles, syringes and drug vials (Hope et al., 2013). Due to the growing use of anabolic 
steroids in the United Kingdom this study explores the experiences of the users and 
investigates their motives, beliefs and steroid-related experiences.
Background literature
Perceptions and management of anabolic steroid-related health harms
Case reports/series, along with observational studies, indicate that acute adverse 
reactions from the pharmacotoxicological actions of anabolic steroids are diverse in their 
characteristics and severity, and include acne, hair loss, gynaecomastia, disruption of 
growth, damage to tendons and ligaments, testicular atrophy, erectile dysfunction, liver 
damage (especially with oral products), and cardiovascular events (Pope et al., in press). 
Use in women can lead to growth of body and facial hair, deepening of voice, clitoris 
enlargement, increased libido, menstruation irregularities, and reduced fertility (Evans-
Brown et al., 2012). Adverse psychological effects have also been reported in the 
literature, including increases in aggressive behaviour, and depression following the 
cessation of use (Haug et al., 2004; ACMD, 2010). Severity of effects is partly 
idiosyncratic, but would also appear to be dose dependent.
One survey conducted amongst members of 18 gyms in the United Arab Emirates 
reported that 59% believed that the benefits of using anabolic steroids outweighed the 
risks (Al-Falasi et al., 2008). A similar study included steroid users attending two needle 
and syringe programmes in the United Kingdom, and found that nearly all of the 
respondents said that they have been given information regarding the potential health 
harms of anabolic steroids and yet more than half had no intention of stopping their use of 
these drugs in the next 12 months (Walker & Joubert, 2011). While these and similar 
studies are beneficial in determining the perceived hazards of steroid use, they offer little 
insights into the reasons behind, and experiences with, the use of these drugs and the 
potential impact on behaviour. In relation to motivation and drivers to use anabolic 
steroids, a significant issue is the apparent relationship between social as well as cultural 
ideals and body satisfaction in men (Mishkind et al., 1986). In terms of studies into body 
image satisfaction, it has been shown that body dissatisfaction, along with the desire to 
enhance muscularity, can prompt the use of anabolic steroids in men (Grogan, 2008). The 
few existing qualitative studies show that users exchange anabolic steroid-related 
knowledge and will often defer to opinion leaders (sometimes referred to as ‘steroid gurus’) 
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and more experienced steroid users (Petrocelli et al., 2008). This knowledge, based 
predominantly on personal experience and anecdotes, includes information on methods to 
reduce or avoid adverse effects (Monaghan, 2001). Here steroid usage is essentially seen 
as a strategic endeavour of control and risk management which may result in some people 
ignoring the potential harms. Beliefs about, and strategies towards, dealing with negative 
affects in individuals are of particular importance in understanding the issue and effectively 
responding to the use of anabolic steroids.
Method
Qualitative interviews with 24 users of anabolic steroids were conducted between 2009 
and 2011 as part of a study of harm reduction services for anabolic steroid users in 
England and Wales (for an overview of respondents see Table 1).  The study had ethical 2
approval granted by Liverpool John Moores Research Ethics Committee. A mix of 
purposive and convenience sampling was utilised in order to select a cross section of 
steroid users (Wengraf, 2001). Seven steroid users were recruited from fixed-site needle 
and syringe programmes; three from an outreach service; nine from steroid clinics; one 
from a gym; and, four from a prison. The majority of respondents had begun their use of 
anabolic steroids around the age of 25, although three had started at the age of 16. The 
oldest respondent was 61 and the youngest 21 (mean age 34 years). Four users were on 
their first course of anabolic steroids at the time of the interview whereas seven had more 
than two decades of experience with these drugs. In this latter group, most were engaged 
in competitive bodybuilding. Only two respondents had taken part in competitive sport 
(rugby and weightlifting) other than bodybuilding (six respondents). Five respondents 
worked as doormen. The sample also included two gym owners, while three individuals 
revealed that they were involved in illicit supplying of anabolic steroids. All the respondents 
were male, reflecting the gender findings of previous studies (Evans-Brown & McVeigh, 
2009; Hope et al., 2013; Leifman et al., 2011). In addition, a number of respondents were 
recruited from harm reduction services; however, many female users engage in 
competitive bodybuilding or other types of sports and may choose therefore to avoid 
health services of fear of being exposed as steroid users (Korkia et al., 1996).
 Services included fixed-site needle and syringe programmes, outreach harm reduction service provision in 2
gyms and so-called steroid clinics providing harm reduction interventions designed specifically for users of 
anabolic steroids. For more information regarding these programmes see (ACMD, 2010).
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Insert table 1
Semi-structured interviews were conducted, lasting between 30 to 75 minutes, 
including questions on body (dis)satisfaction, motivations for steroid usage; patterns of 
steroid use, sources of steroid-related knowledge and accounts of health harms. Most 
interviews were recorded, and subsequently transcribed, except when prison regulation 
prohibited the use of electronic devices, or when respondents felt uncomfortable about 
discussing sensitive issues of using or supplying anabolic steroids. In such cases, a 
written record was compiled immediately after the interview. Written interview records were 
subjected to thematic content analysis in order to identify and verify themes relevant to the 
experiences of steroid usage (Burnard et al., 2008).  Themes were continuously 3
developed and refined as the study progressed (Miles & Huberman, 1994). Analysis 
revealed three broad and chronological themes: steroid use was linked to desires to 
improve appearance; users acquired knowledge from ‘steroid handbooks’, discussion 
forums on the Internet and behavioural examples of peer users in gyms; and, comparisons 
to other groups in society like smokers or people that are obese, who steroid users 
believed were worse off health-wise, made users ignore their own risky behaviour.
Results
Body satisfaction and drugs
In line with previous research into the use of anabolic steroids (Grogan et al., 2006; Evans-
Brown & McVeigh, 2009), findings clearly indicated that anabolic steroid usage was linked 
to getting a better looking body. However, other reasons to use these drugs included 
improvement of strength, maintaining appearance when getting older and enhancement of 
muscle definition. Importantly, reasons to use these drugs may shift over time, providing 
further insights into why users behave as they do:
At this moment in time, I’m not looking to get any bigger as a bodybuilder for 
example. I like to increase my strength, and now it’s more for conditioning. I’m only 
five foot five and I’m around 15 stone.  I wouldn’t wish to be any heavier than that, 4
because carrying more than 15 stone, you are just going to give yourself health 
 The article presents quotes only from interviews recorded on audio.3
 A stone is a unit of weight equivalent to 14 pounds (about 6.35 kg). Fifteen stone is around 95 kg.4
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problems. My next cycle, I’ll be doing a ‘cutting cycle’, I’ll be dieting and getting down 
to a reasonable healthy weight. (Steroid user and doorman aged 35)
The desire to build a better looking body could also be motivated by dissatisfaction 
with other parts of the body besides poor physique, such as male pattern baldness, 
suggesting that self-assessments of bodily discontent is complex and plays a significant 
role in the motivation to change the size or shape of the body:
In all honesty, I think I started weight training more seriously as I was losing my hair 
because I think I started to suffer a loss of confidence, and then I think that sort of 
replaced it, because I felt more confident about myself as I was building my body up. 
(Steroid user aged 35)
Taken together, accounts revealed that the motivation to use these drugs depended 
upon multiple factors including personal and societal bodily ideals. In addition, users 
noticed the improvements they were looking for which in many cases seemed to make the 
risk they associated with these drugs worthwhile. Overall, this provides at least some 
explanation as to why steroid users acknowledged the potential harms of anabolic steroids 
and yet continued their usage.
Gaining and using knowledge
Drug using patterns were complex and highly personalised with no two respondents 
reporting identical regimens. Even so, users told of ‘stacking’, that is taking two or more 
types of steroids at the same time, in an attempt to maximise their efficacy, over a certain 
period of time known as being ‘on’ cycle. Some types of anabolic steroids were used to 
increase ‘bulk’ whereas others were used for ‘cutting’—that is enhancing muscle definition. 
Other distinct categories included ‘weak’ and ‘strong’ anabolic steroids; a classification that 
was used to guide procedures for the ‘stacking’ of specific drugs: 
I started off on testosterone enantate, which is quite a weak one, it’s not ‘quick 
active’. Then I did ‘Deca’ [Deca-Durabolin® (nandrolone decanoate)], two millilitres of 
that and then I got sick [the flu]...‘Deca’ is a strong steroid. You are supposed to mix it 
with Sustanon [Sustanon 250® (blend of four different types of testosterone)], so 
maybe that’s why I got sick. Maybe it’s like, it is a strong steroid and it attacked my 
immune system. (Steroid user aged 22)
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The use of drugs to stimulate the natural production of testosterone during the ‘off’ 
cycle, usually referred to as ‘post-cycle therapy’, was common, as was the use of drugs for 
the self-treatment of steroid induced side effects:
If I get problems with cholesterol, I’ll take statins, which is a drug that can lower 
cholesterol. That helps control that. (Steroid user aged 35)
More complex drug regimens included the use of various anabolic steroids together 
with synthetic growth hormones and insulin to enhance muscle size and lose body fat. 
Additionally, some respondents included sexual enhancement products and skin darkening 
drugs in their drug repertoires (for an overview see Table 2).
Insert table 2
An important part of acquiring knowledge about anabolic steroids—commonly 
referred to by respondents as doing ‘research’—was to ask other users for advice:
My mate was on them, so I started to learn from him. He got on the Internet and 
researched, so that he made sure that he knew what he was doing. (Steroid user 
aged 21)
In fact, there were no indications that any of the respondents engaged in the use of 
steroids on their own. Instead they told of training partners in gyms with whom they 
exchanged knowledge about anabolic steroids. Here steroid users tended to form 
subgroups based on individual characteristics such as those working as doormen or 
competing bodybuilders. Of particular importance is the diffusion of steroid knowledge 
from experienced users, such as competing bodybuilders and gym owners, into groups of 
young and inexperienced users:
...as I got bigger, or if people have seen my photos, and you’ve competed [in 
bodybuilding], you do get people asking for your opinion...that’s nice, because it’s like 
they recognise what you’ve done, and you get a little bit of respect...Younger people 
do ask for advice, whether they want to get bigger or whether they want to compete 
[in bodybuilding] or lose body fat. (Steroid user and competing bodybuilder aged 45)
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Whereas existing studies have highlighted the transfer of knowledge amongst users 
in gyms, (Monaghan, 2001; Grogan et al., 2006), it was clear in this study that the Internet 
was also seen as an important sources of information, particularly when it came down to 
finding information about the types of steroids that are available on the illicit market. Again, 
it seemed that having access to information provided a sense of safety in users:
You do get a lot of ‘counterfeits’ [on the illicit market], but it comes down to the 
Internet. Just go on the Internet, they have pictures, and explain things to look out for. 
It’s just about being switched on really. (Steroid user and doorman aged 27)
Researchers have previously demonstrated how knowledge about different types of 
anabolic steroids, dosages, along with practices for ‘cycling’ and ‘stacking’ are being used 
to plan the use of these drugs in attempts to maximise efficacy and minimise harm 
(Monaghan, 2001). Although this was clear in some users in this study, who kept detailed 
records of their steroid regimes, users also revealed elements of irrationality as they 
ignored the commonly accepted ‘guidelines’ for steroid use and in spur-of-the-moment 
behaviour adopted practices based on rumours which they perceived as ‘emerging 
evidence’. This was typically the case when steroid users heard about the claimed efficacy 
of novel types of drugs, either from other steroid users, illicit suppliers or on the Internet. In 
other cases, recording specific regimes and doses of users presented difficulties (partly 
because of difficulties in remembering the exact duration of previous courses and partly 
because users were unaware of precise amounts or measurements). For example, some 
reported the use of a specific number of millilitres per week or per injection without 
knowing the amount of pharmacologically active substance in vials.
The harmfulness of anabolic steroids: what do users have to say?
About one-third of those interviewed reported adverse reactions which they attributed to 
their anabolic steroid use, including acne, soreness around the nipples, ‘smaller testicles’, 
hair loss, hair growth on the body, high blood pressure and high cholesterol. Of note is that 
many of these were depicted as acceptable side effects of steroid use. One had suffered 
from ‘heart complications’ for which he had received medical treatment in a hospital. 
Furthermore, a number of respondents reported ‘lumps’ and abscesses at the injection 
site.
Simmonds and Coomber (2009) found that steroid users stigmatised other groups of 
drug users, such as intravenous drug users, whom they believed were jeopardising their 
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health. In doing so, steroid users enforced their own sense of being ‘responsible drug 
users’. Similarly, respondents in this study expressed that the use of anabolic steroids, 
along with their training regimes, was a healthier alternative to a sedentary lifestyle, 
obesity, ‘drinking in weekends’ and using recreational drugs. For instance, according to 
this user (working as a doorman), recreational drugs were the cause of violence in the 
night-time economy, not anabolic steroids:
Working as a doorman I get provoked every night. But what I see is that with the kind 
of people who are stereotyped as ‘roid rage’ people—and I see how these people 
conduct themselves on a regular basis—it’s the alcohol and the drugs [stimulants] 
that are making them angry. It’s just that they look muscular at the same time, and 
that is where the ‘roid rage’ comes from. (Steroid user and doorman aged 35)
By contrast, one respondent claimed (below) he had stopped using steroids because 
he believed they made him behave more aggressively. Of note is that his account also 
revealed incidents of violence in the night-life environment, conflicts with the police and 
serving time in prison. Additionally he reported the use of alcohol and cocaine. For these 
reasons, it is not possible to identify the role that the pharmacological effects of anabolic 
steroids played in causing the aggressive behaviour given that the use of cocaine and 
alcohol, underlying personality traits, together with environmental and local cultural and 
social factors, cannot be ignored (Eisenegger et al., 2010; Mazur, 2005).
I got bigger, I got stronger, but I also got nasty and more aggressive, and the two put 
together was dangerous. I kept fighting all the time and used to get myself locked up, 
and in the end it wasn’t working. I could be really nasty. I was a horrible person to talk 
to. (Steroid user and rugby player aged 23)
Despite contradicting viewpoints pertaining to the harms of anabolic steroids, most 
steroid users in this study seemed to agree with this viewpoint: ‘very few people suffer any 
serious side effects, if any at all’ (Steroid user, competing bodybuilder and gym owner 
aged 45). Tellingly for the general perception of the harmfulness of anabolic steroids, the 
respondent below used three different types of anabolic steroids at the same time, in 
dosages of 1,000 mg per week, and yet perceived himself to be of better health now than 
before he started using these drugs.
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I enjoy weight training, certainly when I’m not in the gym I miss going to the gym and 
I wouldn’t like to let myself get back to the kind of health and body shape that I used 
to have before I got into it. (Steroid user aged 35)
Discussion
Numerous factors including perceptions of the ideal body, steroid knowledge shared 
amongst users, the function of the illicit market, and personal assessments of health 
influenced the motivations and beliefs amongst steroid users. Users did not generally 
express anxiety over the possible harms of these drugs as many told that these could be 
avoided, or at least minimised by accessing knowledge about anabolic steroids embedded 
within groups of users in gyms and diffusing on the Internet. This resonates with work of 
Monaghan (2001), highlighting that many users distinguish between ‘sensible’ and well-
organised steroid use contra the ‘abuse’ of these drugs such as ‘high’ and unplanned 
dosages of multiple drugs.
A significant finding was that comparisons between themselves; for example training 
regularly and thus being part of a gym lifestyle which is generally accepted as healthy, and 
other groups in society, such as people who are obese, smokers and recreational drug 
users, appeared to function as a mechanism to downplay the risk of anabolic steroid use 
as portrayed by people outside steroid using cultures. The fact that a number of 
respondents told that their current lifestyle had replaced former health problems such as 
depression, poor physique/obesity, back pain and recreational drug usage (cannabis 
smoking) further enhanced their belief that they are healthier than other populations in 
society. Overall, this appeared to serve multiple purposes, including questioning the 
trustworthiness of information about the potential harms of these drugs from health 
authorities, and coping with insecurities about the use of these drugs by increasing the 
sense of security and well-being (Wills, 1981). Overall, accounts left the impression that as 
a result of the norms and practices within the environment of steroid use, many users 
believed that these drugs can be used relatively safely.
The accounts of steroid users revealed tremendous inconsistencies in the perception 
of the harms of anabolic steroids between users and health authorities, the media and 
policymakers with serious implications for the promotion of public health. Further 
difficulties arise from the gaps in our understanding and inability to quantify the potential 
health harms of these drugs (ACMD, 2010). Importantly in this respect, the exact extent 
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and severity of harms caused by the self-administration of anabolic steroids has never 
been quantified (Pope et al., in press). In addition, the denial of the efficacy of anabolic 
steroids followed by unsupported health warnings about the harms of anabolic steroids 
has resulted in barriers to credibility and trust (Dawson, 2001; Grogan et al., 2006; 
Petrocelli et al., 2008). It is paramount therefore to gauge more accurately the risks of 
anabolic steroid usage in order to being able to provide users with unambiguous advice. 
However of equal importance is that the exploration of problems, harms and benefits of 
steroid usage as seen by the users themselves is used in the process of developing public 
health strategies (including harm reduction interventions) that are credible and effective.
The significant role of the ‘steroid guru’ (opinion leaders) may be seen as a barrier to 
the delivery of effective harm reduction information to users of anabolic steroids and 
associated drugs. However, this may also offer a potential opportunity to deliver accurate 
information via an established and credible communication network. Engagement with the 
most influential members of the steroid using community may be the initial stage in 
providing accessible and acceptable health related information.
It is important to consider the limitations of this study. It was not possible to recruit 
female users in this study, reflecting the relatively low level of anabolic steroid use by 
women in the United Kingdom (ACMD, 2010). All respondents had been in contact with 
harm reduction services and it is not possible to know if these individuals are truly 
representative of the wider population of anabolic steroid users who may have never 
presented to services. The recording of drug regimes, in terms of types of drugs being 
used and dosage, rely on self-reports, which may not be accurate. Given that users 
obtained their drugs from the illicit market their exact composition cannot be determined 
without submitting them to drug testing and analysis (Evans-Brown et al., 2009). 
Considering these limitations is important when extrapolating the findings to the wider 
population of anabolic steroid users.
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Table 1. Respondent profiles.a
Participant Age Area Type of harm 
reduction service 
attended
User 
characteristicsb
1 22 North West of 
England
Steroid clinic Inexperienced user
2 27 North West of 
England
Steroid clinic Doorman, very 
experienced user
3 21 North West of 
England
Steroid clinic Doorman, 
experienced user
4 22 North West of 
England
Steroid clinic Inexperienced user
5 21 North West of 
England
Steroid clinic Inexperienced user
6 21 North West of 
England
Steroid clinic Inexperienced user
7 37 London Steroid clinic Inexperienced user
8 27 London Steroid clinic Inexperienced user
9 36 North West of 
England
Conventional 
needle and syringe 
programme
Doorman, 
experienced user
10 61 North West of 
England
Conventional 
needle and syringe 
programme
Competing 
bodybuilder, very 
experienced user
11 29 North West of 
England
Conventional 
needle and syringe 
programme
Experienced user
12 35 North East of 
England
Steroid clinic Doorman, 
experienced user
13 35 North West of 
England
Conventional 
needle and syringe 
programme
Competing 
bodybuilder, gym 
owner, involved in 
illicit steroid supply, 
very experienced 
user
14 39 South of England Outreach service Competitive 
weightlifter, 
involved in illicit 
steroid supply, very 
experienced user
aStudy included 24 (male) users of anabolic steroids, aged 21 to 61 (mean 34 years).
bFour groups of steroid users can be identified based on the predominant reason to use 
these drugs: 1. sports competitors (including competing bodybuilders); 2. occupational 
users (such as ‘doormen’); 3. those using as treatment or anti-ageing; and, 4. usage for 
cosmetic reasons to enhance body satisfaction (Evans-Brown et al., 2012). This present 
study includes users from all four categories.
15 35 South of England Outreach service Competing 
bodybuilder, 
involved in illicit 
steroid supply, very 
experienced user
16 45 South of England Outreach service Experienced user
17 45 South Wales Conventional 
needle and syringe 
programme
Competing 
bodybuilder, gym 
owner, very 
experienced user
18 23 South Wales Conventional 
needle and syringe 
programme
Rugby player, 
inexperienced user
19 27 South Wales Conventional 
needle and syringe 
programme
Fitness trainer, 
inexperienced user
20 45 South Wales Conventional 
needle and syringe 
programme
Competing 
bodybuilder, very 
experienced user
21 34 South Wales Conventional 
needle and syringe 
programme
Experienced user
22 50 South Wales Conventional 
needle and syringe 
programme
Very experienced 
user
23 55 South Wales Conventional 
needle and syringe 
programme
Competing 
bodybuilder, 
doorman, very 
experienced user
24 34 South Wales Conventional 
needle and syringe 
programme
Experienced user
Table 2. Respondents’ uses of drugs for human enhancement purposes.
Name Respondents’ reasons for use Effects
Anabolic steroids Increase performance during work 
out, enhance appearance of the 
body, anti-ageing
Synthetic male sex hormone with 
similar effects as testosterone
Growth hormones Their anabolic effects and to 
enhance weight loss
Synthetic peptide hormone 
involved in growth and fat 
metabolism
Clenbuterol Enhance weight loss and for its 
anabolic properties
A sympathomimetic prescribed in 
some countries as a 
bronchodilator. Increases the 
metabolic rate
Insulin For weight loss and its anabolic 
properties
Hormone responsible for control of 
blood sugar and metabolism of fat 
and carbohydrates
hCG (human chorionic 
gonadotropin)
To trigger the production of 
testosterone in the body after the 
end of a steroid course
A hormone produced by women 
during pregnancy. Stimulates 
testosterone production in the body
Tamoxifen Combats the negative effects of 
steroid use, e.g. gynaecomastia, 
by preventing the action of 
oestrogen
An anti-oestrogen prescribed for 
treatment of breast cancer that 
blocks the effect of oestrogen
Melanotan II For skin tanning, in preparation for 
bodybuilding competition
A synthetic peptide that increases 
levels of melanin resulting in skin 
pigmentation
Ephedrine Enhance weight loss A stimulant used as a 
decongestant and to raise blood 
pressure. Increases metabolic rate
Sildenafil Enhance sexual function A phosphodiasterase type 5 
inhibitor sold under the trade name 
Viagra®. Increases blood flow to 
the penis and causes erection
Amphetamine To induce aggressiveness during 
work out
Synthetic stimulant
